Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

Sorted by: relevance · author · university · dateNew search

You searched for subject:(glucagon like peptide 1 GLP 1 ). Showing records 1 – 30 of 23359 total matches.

[1] [2] [3] [4] [5] … [779]

Search Limiters

Last 2 Years | English Only

Levels

Languages

Country

▼ Search Limiters


University of Cambridge

1. Clarke, Sophie. The Cardiovascular Effect of GLP-1 in Humans.

Degree: PhD, 2019, University of Cambridge

 The incretin glucagon-like peptide-1 (GLP-1) abolishes post-ischemic left ventricular contractility (stunning) in humans but the mechanism remains elusive. I hypothesized that this effect is mediated… (more)

Subjects/Keywords: glucagon-like peptide-1; cardioprotection; GLP-1; coronary haemodynamics

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Clarke, S. (2019). The Cardiovascular Effect of GLP-1 in Humans. (Doctoral Dissertation). University of Cambridge. Retrieved from https://www.repository.cam.ac.uk/handle/1810/294378

Chicago Manual of Style (16th Edition):

Clarke, Sophie. “The Cardiovascular Effect of GLP-1 in Humans.” 2019. Doctoral Dissertation, University of Cambridge. Accessed April 17, 2021. https://www.repository.cam.ac.uk/handle/1810/294378.

MLA Handbook (7th Edition):

Clarke, Sophie. “The Cardiovascular Effect of GLP-1 in Humans.” 2019. Web. 17 Apr 2021.

Vancouver:

Clarke S. The Cardiovascular Effect of GLP-1 in Humans. [Internet] [Doctoral dissertation]. University of Cambridge; 2019. [cited 2021 Apr 17]. Available from: https://www.repository.cam.ac.uk/handle/1810/294378.

Council of Science Editors:

Clarke S. The Cardiovascular Effect of GLP-1 in Humans. [Doctoral Dissertation]. University of Cambridge; 2019. Available from: https://www.repository.cam.ac.uk/handle/1810/294378


University of Cambridge

2. Clarke, Sophie. The cardiovascular effect of GLP-1 in humans.

Degree: PhD, 2019, University of Cambridge

 The incretin glucagon-like peptide-1 (GLP-1) abolishes post-ischemic left ventricular contractility (stunning) in humans but the mechanism remains elusive. I hypothesized that this effect is mediated… (more)

Subjects/Keywords: glucagon-like peptide-1; cardioprotection; GLP-1; coronary haemodynamics

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Clarke, S. (2019). The cardiovascular effect of GLP-1 in humans. (Doctoral Dissertation). University of Cambridge. Retrieved from https://doi.org/10.17863/CAM.41479 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.782790

Chicago Manual of Style (16th Edition):

Clarke, Sophie. “The cardiovascular effect of GLP-1 in humans.” 2019. Doctoral Dissertation, University of Cambridge. Accessed April 17, 2021. https://doi.org/10.17863/CAM.41479 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.782790.

MLA Handbook (7th Edition):

Clarke, Sophie. “The cardiovascular effect of GLP-1 in humans.” 2019. Web. 17 Apr 2021.

Vancouver:

Clarke S. The cardiovascular effect of GLP-1 in humans. [Internet] [Doctoral dissertation]. University of Cambridge; 2019. [cited 2021 Apr 17]. Available from: https://doi.org/10.17863/CAM.41479 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.782790.

Council of Science Editors:

Clarke S. The cardiovascular effect of GLP-1 in humans. [Doctoral Dissertation]. University of Cambridge; 2019. Available from: https://doi.org/10.17863/CAM.41479 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.782790


Rutgers University

3. Kreitman, Alexandra, 1995-. Bone turnover and GLP-1 respond to a putative α-glucosidase inhibitor.

Degree: MS, Nutritional Sciences, 2019, Rutgers University

 The botanical, Salacia chinensis (SC), has α-glucosidase inhibitor (α-GI) properties that attenuates postprandial glycemic indices and increases secretion of glucagon-like peptide (GLP-1), a gut peptide(more)

Subjects/Keywords: GLP-1; Glucagon-like peptide 1; Glucosidase inhibitors

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Kreitman, Alexandra, 1. (2019). Bone turnover and GLP-1 respond to a putative α-glucosidase inhibitor. (Masters Thesis). Rutgers University. Retrieved from https://rucore.libraries.rutgers.edu/rutgers-lib/61784/

Chicago Manual of Style (16th Edition):

Kreitman, Alexandra, 1995-. “Bone turnover and GLP-1 respond to a putative α-glucosidase inhibitor.” 2019. Masters Thesis, Rutgers University. Accessed April 17, 2021. https://rucore.libraries.rutgers.edu/rutgers-lib/61784/.

MLA Handbook (7th Edition):

Kreitman, Alexandra, 1995-. “Bone turnover and GLP-1 respond to a putative α-glucosidase inhibitor.” 2019. Web. 17 Apr 2021.

Vancouver:

Kreitman, Alexandra 1. Bone turnover and GLP-1 respond to a putative α-glucosidase inhibitor. [Internet] [Masters thesis]. Rutgers University; 2019. [cited 2021 Apr 17]. Available from: https://rucore.libraries.rutgers.edu/rutgers-lib/61784/.

Council of Science Editors:

Kreitman, Alexandra 1. Bone turnover and GLP-1 respond to a putative α-glucosidase inhibitor. [Masters Thesis]. Rutgers University; 2019. Available from: https://rucore.libraries.rutgers.edu/rutgers-lib/61784/

4. Richard, Jennifer. Central actions of glucagon-like peptide-1 on food intake and reward: Novel neurological targets and sex divergent effects.

Degree: 2019, University of Gothenburg / Göteborgs Universitet

 Obesity is one of the biggest health risks of our society; however, treatment options are sparse and often result in suboptimal weight-loss. The glucagon-like peptide-1(more)

Subjects/Keywords: Glucagon-like peptide-1; Food reward; Food intake; GLP-1; Sex differences

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Richard, J. (2019). Central actions of glucagon-like peptide-1 on food intake and reward: Novel neurological targets and sex divergent effects. (Thesis). University of Gothenburg / Göteborgs Universitet. Retrieved from http://hdl.handle.net/2077/62214

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Richard, Jennifer. “Central actions of glucagon-like peptide-1 on food intake and reward: Novel neurological targets and sex divergent effects.” 2019. Thesis, University of Gothenburg / Göteborgs Universitet. Accessed April 17, 2021. http://hdl.handle.net/2077/62214.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Richard, Jennifer. “Central actions of glucagon-like peptide-1 on food intake and reward: Novel neurological targets and sex divergent effects.” 2019. Web. 17 Apr 2021.

Vancouver:

Richard J. Central actions of glucagon-like peptide-1 on food intake and reward: Novel neurological targets and sex divergent effects. [Internet] [Thesis]. University of Gothenburg / Göteborgs Universitet; 2019. [cited 2021 Apr 17]. Available from: http://hdl.handle.net/2077/62214.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Richard J. Central actions of glucagon-like peptide-1 on food intake and reward: Novel neurological targets and sex divergent effects. [Thesis]. University of Gothenburg / Göteborgs Universitet; 2019. Available from: http://hdl.handle.net/2077/62214

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

5. Grasset, Estelle. Mécanismes moléculaires régulant l'action du glucagon-like peptide one dans la physiopathologie du diabète de type 2 : Molecular mechanisms regulating glucagon-like peptide one action in type 2 diabetes.

Degree: Docteur es, Maladies métaboliques et cardiovasculaires, 2016, Université Toulouse III – Paul Sabatier

Selon l'organisation mondiale de la santé, le diabète de type II (DT2), caractérisé par un défaut de contrôle de la glycémie, est une des causes… (more)

Subjects/Keywords: Glucagon-like peptide one (GLP-1); Diabètes; Récepteur au GLP-1; Microbiote intestinal; Neurones; Clock genes; Intestin

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Grasset, E. (2016). Mécanismes moléculaires régulant l'action du glucagon-like peptide one dans la physiopathologie du diabète de type 2 : Molecular mechanisms regulating glucagon-like peptide one action in type 2 diabetes. (Doctoral Dissertation). Université Toulouse III – Paul Sabatier. Retrieved from http://www.theses.fr/2016TOU30301

Chicago Manual of Style (16th Edition):

Grasset, Estelle. “Mécanismes moléculaires régulant l'action du glucagon-like peptide one dans la physiopathologie du diabète de type 2 : Molecular mechanisms regulating glucagon-like peptide one action in type 2 diabetes.” 2016. Doctoral Dissertation, Université Toulouse III – Paul Sabatier. Accessed April 17, 2021. http://www.theses.fr/2016TOU30301.

MLA Handbook (7th Edition):

Grasset, Estelle. “Mécanismes moléculaires régulant l'action du glucagon-like peptide one dans la physiopathologie du diabète de type 2 : Molecular mechanisms regulating glucagon-like peptide one action in type 2 diabetes.” 2016. Web. 17 Apr 2021.

Vancouver:

Grasset E. Mécanismes moléculaires régulant l'action du glucagon-like peptide one dans la physiopathologie du diabète de type 2 : Molecular mechanisms regulating glucagon-like peptide one action in type 2 diabetes. [Internet] [Doctoral dissertation]. Université Toulouse III – Paul Sabatier; 2016. [cited 2021 Apr 17]. Available from: http://www.theses.fr/2016TOU30301.

Council of Science Editors:

Grasset E. Mécanismes moléculaires régulant l'action du glucagon-like peptide one dans la physiopathologie du diabète de type 2 : Molecular mechanisms regulating glucagon-like peptide one action in type 2 diabetes. [Doctoral Dissertation]. Université Toulouse III – Paul Sabatier; 2016. Available from: http://www.theses.fr/2016TOU30301


Addis Ababa University

6. Dereje, Getachew. The role of incretin hormone in type 2 diabetes .

Degree: 2012, Addis Ababa University

 Background: Type 2 diabetes mellitus is a metabolic disease associated with low quality of life and early death. It is now well established that beta-cell… (more)

Subjects/Keywords: Incretin effect; Polypeptide (GIP); Glucose Dependent Insulinotropic; Glucagon Like Peptide-1(GLP-1); Type 2 diabetes

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Dereje, G. (2012). The role of incretin hormone in type 2 diabetes . (Thesis). Addis Ababa University. Retrieved from http://etd.aau.edu.et/dspace/handle/123456789/1565

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Dereje, Getachew. “The role of incretin hormone in type 2 diabetes .” 2012. Thesis, Addis Ababa University. Accessed April 17, 2021. http://etd.aau.edu.et/dspace/handle/123456789/1565.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Dereje, Getachew. “The role of incretin hormone in type 2 diabetes .” 2012. Web. 17 Apr 2021.

Vancouver:

Dereje G. The role of incretin hormone in type 2 diabetes . [Internet] [Thesis]. Addis Ababa University; 2012. [cited 2021 Apr 17]. Available from: http://etd.aau.edu.et/dspace/handle/123456789/1565.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Dereje G. The role of incretin hormone in type 2 diabetes . [Thesis]. Addis Ababa University; 2012. Available from: http://etd.aau.edu.et/dspace/handle/123456789/1565

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Toronto

7. Stacey, Holly Maryanne. The Role of Syntaxin-1a in Glucagon-like Peptide-1 Secretion from the Adult Mouse Intestinal L-Cell.

Degree: 2015, University of Toronto

Glucagon-like Peptide-1 (GLP-1) is an incretin secreted from intestinal L-cells. Although pathways promoting GLP-1 secretion have been characterized, little is known about the mechanism of… (more)

Subjects/Keywords: Exocytosis; Glucagon-like Peptide-1 (GLP-1); in vivo; Primary L-Cell; Secretion; Syntaxin-1a; 0719

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Stacey, H. M. (2015). The Role of Syntaxin-1a in Glucagon-like Peptide-1 Secretion from the Adult Mouse Intestinal L-Cell. (Masters Thesis). University of Toronto. Retrieved from http://hdl.handle.net/1807/70774

Chicago Manual of Style (16th Edition):

Stacey, Holly Maryanne. “The Role of Syntaxin-1a in Glucagon-like Peptide-1 Secretion from the Adult Mouse Intestinal L-Cell.” 2015. Masters Thesis, University of Toronto. Accessed April 17, 2021. http://hdl.handle.net/1807/70774.

MLA Handbook (7th Edition):

Stacey, Holly Maryanne. “The Role of Syntaxin-1a in Glucagon-like Peptide-1 Secretion from the Adult Mouse Intestinal L-Cell.” 2015. Web. 17 Apr 2021.

Vancouver:

Stacey HM. The Role of Syntaxin-1a in Glucagon-like Peptide-1 Secretion from the Adult Mouse Intestinal L-Cell. [Internet] [Masters thesis]. University of Toronto; 2015. [cited 2021 Apr 17]. Available from: http://hdl.handle.net/1807/70774.

Council of Science Editors:

Stacey HM. The Role of Syntaxin-1a in Glucagon-like Peptide-1 Secretion from the Adult Mouse Intestinal L-Cell. [Masters Thesis]. University of Toronto; 2015. Available from: http://hdl.handle.net/1807/70774


University of Toronto

8. Poreba, Monika. Role of Fatty Acid Transport Proteins in Oleic Acid-induced Secretion of Glucagon-like Peptide-1.

Degree: 2011, University of Toronto

Glucagon-like peptide-1 (GLP-1) is an anti-diabetic intestinal L cell hormone. The monounsaturated fatty acid, oleic acid (OA), is an effective GLP-1 secretagogue that crosses the… (more)

Subjects/Keywords: oleic acid; fatty acid transport proteins; glucagon-like peptide-1; GLP-1; L cell; diabetes; 0719

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Poreba, M. (2011). Role of Fatty Acid Transport Proteins in Oleic Acid-induced Secretion of Glucagon-like Peptide-1. (Masters Thesis). University of Toronto. Retrieved from http://hdl.handle.net/1807/31387

Chicago Manual of Style (16th Edition):

Poreba, Monika. “Role of Fatty Acid Transport Proteins in Oleic Acid-induced Secretion of Glucagon-like Peptide-1.” 2011. Masters Thesis, University of Toronto. Accessed April 17, 2021. http://hdl.handle.net/1807/31387.

MLA Handbook (7th Edition):

Poreba, Monika. “Role of Fatty Acid Transport Proteins in Oleic Acid-induced Secretion of Glucagon-like Peptide-1.” 2011. Web. 17 Apr 2021.

Vancouver:

Poreba M. Role of Fatty Acid Transport Proteins in Oleic Acid-induced Secretion of Glucagon-like Peptide-1. [Internet] [Masters thesis]. University of Toronto; 2011. [cited 2021 Apr 17]. Available from: http://hdl.handle.net/1807/31387.

Council of Science Editors:

Poreba M. Role of Fatty Acid Transport Proteins in Oleic Acid-induced Secretion of Glucagon-like Peptide-1. [Masters Thesis]. University of Toronto; 2011. Available from: http://hdl.handle.net/1807/31387


University of Toronto

9. Panjwani, Naim. The Role of the Glucagon-like Peptide-1 Receptor in Atherosclerosis.

Degree: 2012, University of Toronto

Objective: Glucagon-like peptide-1 receptor (GLP-1R) agonists have been shown to reduce atherosclerosis in non-diabetic mice. We hypothesized that treatment with GLP-1R agonists would reduce the… (more)

Subjects/Keywords: diabetes; atherosclerosis; glp-1; glucagon-like peptide-1; cardiovascular disease; ApoE; mice; hepatic steatosis; 0306; 0719

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Panjwani, N. (2012). The Role of the Glucagon-like Peptide-1 Receptor in Atherosclerosis. (Masters Thesis). University of Toronto. Retrieved from http://hdl.handle.net/1807/42405

Chicago Manual of Style (16th Edition):

Panjwani, Naim. “The Role of the Glucagon-like Peptide-1 Receptor in Atherosclerosis.” 2012. Masters Thesis, University of Toronto. Accessed April 17, 2021. http://hdl.handle.net/1807/42405.

MLA Handbook (7th Edition):

Panjwani, Naim. “The Role of the Glucagon-like Peptide-1 Receptor in Atherosclerosis.” 2012. Web. 17 Apr 2021.

Vancouver:

Panjwani N. The Role of the Glucagon-like Peptide-1 Receptor in Atherosclerosis. [Internet] [Masters thesis]. University of Toronto; 2012. [cited 2021 Apr 17]. Available from: http://hdl.handle.net/1807/42405.

Council of Science Editors:

Panjwani N. The Role of the Glucagon-like Peptide-1 Receptor in Atherosclerosis. [Masters Thesis]. University of Toronto; 2012. Available from: http://hdl.handle.net/1807/42405


Virginia Tech

10. Haufe, Thomas Carl. Grape powder attenuates the negative effects of GLP-1 receptor antagonism by exendin-3 (9-39) in a normoglycemic mouse model.

Degree: MSin Life Sciences, Food Science and Technology, 2016, Virginia Tech

 Prediabetes is a condition affecting 35% of US adults and about 50% of US adults age 65+. Foods rich in polyphenols, including flavanols and other… (more)

Subjects/Keywords: grape powder; procyanidins; incretin; exendin-3; prediabetes; obesity; glucose tolerance; glucagon-like peptide 1; GLP-1

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Haufe, T. C. (2016). Grape powder attenuates the negative effects of GLP-1 receptor antagonism by exendin-3 (9-39) in a normoglycemic mouse model. (Masters Thesis). Virginia Tech. Retrieved from http://hdl.handle.net/10919/80344

Chicago Manual of Style (16th Edition):

Haufe, Thomas Carl. “Grape powder attenuates the negative effects of GLP-1 receptor antagonism by exendin-3 (9-39) in a normoglycemic mouse model.” 2016. Masters Thesis, Virginia Tech. Accessed April 17, 2021. http://hdl.handle.net/10919/80344.

MLA Handbook (7th Edition):

Haufe, Thomas Carl. “Grape powder attenuates the negative effects of GLP-1 receptor antagonism by exendin-3 (9-39) in a normoglycemic mouse model.” 2016. Web. 17 Apr 2021.

Vancouver:

Haufe TC. Grape powder attenuates the negative effects of GLP-1 receptor antagonism by exendin-3 (9-39) in a normoglycemic mouse model. [Internet] [Masters thesis]. Virginia Tech; 2016. [cited 2021 Apr 17]. Available from: http://hdl.handle.net/10919/80344.

Council of Science Editors:

Haufe TC. Grape powder attenuates the negative effects of GLP-1 receptor antagonism by exendin-3 (9-39) in a normoglycemic mouse model. [Masters Thesis]. Virginia Tech; 2016. Available from: http://hdl.handle.net/10919/80344


University of Cambridge

11. Brichtova, Eva. Studies on the physical stability of a C-terminally amidated variant of GLP-1.

Degree: MPhil, 2019, University of Cambridge

 The phenomenon of peptide and protein aggregation is of great biochemical importance. Not only is it a key feature of numerous neurodegenerative diseases such as… (more)

Subjects/Keywords: peptide aggregation; glucagon-like peptide 1; GLP-1; peptide therapeutics; peptide stability; off-pathway oligomers; peptide oligomers; amyloid fibrils; metastable oligomers; amyloid aggregates; peptide degradation; fibrillation; misfolding; diabetes

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Brichtova, E. (2019). Studies on the physical stability of a C-terminally amidated variant of GLP-1. (Masters Thesis). University of Cambridge. Retrieved from https://www.repository.cam.ac.uk/handle/1810/296886

Chicago Manual of Style (16th Edition):

Brichtova, Eva. “Studies on the physical stability of a C-terminally amidated variant of GLP-1.” 2019. Masters Thesis, University of Cambridge. Accessed April 17, 2021. https://www.repository.cam.ac.uk/handle/1810/296886.

MLA Handbook (7th Edition):

Brichtova, Eva. “Studies on the physical stability of a C-terminally amidated variant of GLP-1.” 2019. Web. 17 Apr 2021.

Vancouver:

Brichtova E. Studies on the physical stability of a C-terminally amidated variant of GLP-1. [Internet] [Masters thesis]. University of Cambridge; 2019. [cited 2021 Apr 17]. Available from: https://www.repository.cam.ac.uk/handle/1810/296886.

Council of Science Editors:

Brichtova E. Studies on the physical stability of a C-terminally amidated variant of GLP-1. [Masters Thesis]. University of Cambridge; 2019. Available from: https://www.repository.cam.ac.uk/handle/1810/296886


Aristotle University Of Thessaloniki (AUTH); Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης (ΑΠΘ)

12. Liakos, Aris. Μία τυχαιοποιημένη, διπλά τυφλή, ελεγχόμενη με εικονικό φάρμακο μελέτη της επίδρασης της λιραγλουτίδης στην αρτηριακή πίεση υπερτασικών ασθενών με σακχαρώδη διαβήτη τύπου 2.

Degree: 2019, Aristotle University Of Thessaloniki (AUTH); Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης (ΑΠΘ)

Incidence of type 2 diabetes mellitus (T2DM) has been continually rising during the past years as a result of sedentary lifestyle and increasing prevalence of… (more)

Subjects/Keywords: Σακχαρώδης διαβήτης τύπου 2; Αρτηριακή υπέρταση; Λιραγλουτίδη; Αγωνιστές των υποδοχέων του γλυκαγονόμορφου πεπτιδίου 1; Type 2 diabetes mellitus; Arterial hypertension; liraglutide; Glucagon-like peptide 1 (GLP-1) receptor agonists

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Liakos, A. (2019). Μία τυχαιοποιημένη, διπλά τυφλή, ελεγχόμενη με εικονικό φάρμακο μελέτη της επίδρασης της λιραγλουτίδης στην αρτηριακή πίεση υπερτασικών ασθενών με σακχαρώδη διαβήτη τύπου 2. (Thesis). Aristotle University Of Thessaloniki (AUTH); Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης (ΑΠΘ). Retrieved from http://hdl.handle.net/10442/hedi/45592

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Liakos, Aris. “Μία τυχαιοποιημένη, διπλά τυφλή, ελεγχόμενη με εικονικό φάρμακο μελέτη της επίδρασης της λιραγλουτίδης στην αρτηριακή πίεση υπερτασικών ασθενών με σακχαρώδη διαβήτη τύπου 2.” 2019. Thesis, Aristotle University Of Thessaloniki (AUTH); Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης (ΑΠΘ). Accessed April 17, 2021. http://hdl.handle.net/10442/hedi/45592.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Liakos, Aris. “Μία τυχαιοποιημένη, διπλά τυφλή, ελεγχόμενη με εικονικό φάρμακο μελέτη της επίδρασης της λιραγλουτίδης στην αρτηριακή πίεση υπερτασικών ασθενών με σακχαρώδη διαβήτη τύπου 2.” 2019. Web. 17 Apr 2021.

Vancouver:

Liakos A. Μία τυχαιοποιημένη, διπλά τυφλή, ελεγχόμενη με εικονικό φάρμακο μελέτη της επίδρασης της λιραγλουτίδης στην αρτηριακή πίεση υπερτασικών ασθενών με σακχαρώδη διαβήτη τύπου 2. [Internet] [Thesis]. Aristotle University Of Thessaloniki (AUTH); Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης (ΑΠΘ); 2019. [cited 2021 Apr 17]. Available from: http://hdl.handle.net/10442/hedi/45592.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Liakos A. Μία τυχαιοποιημένη, διπλά τυφλή, ελεγχόμενη με εικονικό φάρμακο μελέτη της επίδρασης της λιραγλουτίδης στην αρτηριακή πίεση υπερτασικών ασθενών με σακχαρώδη διαβήτη τύπου 2. [Thesis]. Aristotle University Of Thessaloniki (AUTH); Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης (ΑΠΘ); 2019. Available from: http://hdl.handle.net/10442/hedi/45592

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Vanderbilt University

13. Johnson, Kathryn Mercedes Stettler. The role of physiological elevations of glucagon-like peptide-one in glucose regulation in the dog in vivo.

Degree: PhD, Molecular Physiology and Biophysics, 2008, Vanderbilt University

Glucagon-like peptide-one (GLP-1) secreted from the endocrine L cell in the gut after a meal results in elevations of the peptide in arterial blood, the… (more)

Subjects/Keywords: hepatic portal vein; Glucagon-like peptide-1  – Physiological effect; Glucose  – Metabolism; GLP-1

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Johnson, K. M. S. (2008). The role of physiological elevations of glucagon-like peptide-one in glucose regulation in the dog in vivo. (Doctoral Dissertation). Vanderbilt University. Retrieved from http://hdl.handle.net/1803/12078

Chicago Manual of Style (16th Edition):

Johnson, Kathryn Mercedes Stettler. “The role of physiological elevations of glucagon-like peptide-one in glucose regulation in the dog in vivo.” 2008. Doctoral Dissertation, Vanderbilt University. Accessed April 17, 2021. http://hdl.handle.net/1803/12078.

MLA Handbook (7th Edition):

Johnson, Kathryn Mercedes Stettler. “The role of physiological elevations of glucagon-like peptide-one in glucose regulation in the dog in vivo.” 2008. Web. 17 Apr 2021.

Vancouver:

Johnson KMS. The role of physiological elevations of glucagon-like peptide-one in glucose regulation in the dog in vivo. [Internet] [Doctoral dissertation]. Vanderbilt University; 2008. [cited 2021 Apr 17]. Available from: http://hdl.handle.net/1803/12078.

Council of Science Editors:

Johnson KMS. The role of physiological elevations of glucagon-like peptide-one in glucose regulation in the dog in vivo. [Doctoral Dissertation]. Vanderbilt University; 2008. Available from: http://hdl.handle.net/1803/12078


Freie Universität Berlin

14. Tacke, Matthias M. Clinical significance of co-morbidities in chronic heart failure.

Degree: 2014, Freie Universität Berlin

 Introduction: The prognosis of chronic heart failure (HF) is influenced by co- morbidities. We investigated smoking, muscle wasting and resting energy expenditure (REE) in patients… (more)

Subjects/Keywords: heart failure; muscle wasting; sarcopenia; cachexia; resting energy expenditure; glucagon-like peptide 1; GLP-1; smoking; 600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Tacke, M. M. (2014). Clinical significance of co-morbidities in chronic heart failure. (Thesis). Freie Universität Berlin. Retrieved from https://refubium.fu-berlin.de/handle/fub188/13505

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Tacke, Matthias M. “Clinical significance of co-morbidities in chronic heart failure.” 2014. Thesis, Freie Universität Berlin. Accessed April 17, 2021. https://refubium.fu-berlin.de/handle/fub188/13505.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Tacke, Matthias M. “Clinical significance of co-morbidities in chronic heart failure.” 2014. Web. 17 Apr 2021.

Vancouver:

Tacke MM. Clinical significance of co-morbidities in chronic heart failure. [Internet] [Thesis]. Freie Universität Berlin; 2014. [cited 2021 Apr 17]. Available from: https://refubium.fu-berlin.de/handle/fub188/13505.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Tacke MM. Clinical significance of co-morbidities in chronic heart failure. [Thesis]. Freie Universität Berlin; 2014. Available from: https://refubium.fu-berlin.de/handle/fub188/13505

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Cambridge

15. Roth, Emma Maria. Central mechanisms underlying the synergistic anorectic effect of CCK and GLP-1 combination therapy.

Degree: PhD, 2020, University of Cambridge

 Combination therapies that enhance the effects of separate peptides while limiting adverse effects constitute a promising strategy to improve the efficacy of pharmacologic-based treatments of… (more)

Subjects/Keywords: CCK; GLP-1; combination; satiety; neuroanatomy; synergy; energy metabolism; food intake; c-fos; immunohistochemistry; phosphorylated ribosome capture; pTRAP; cholecystokinin; glucagon-like peptide-1; obesity

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Roth, E. M. (2020). Central mechanisms underlying the synergistic anorectic effect of CCK and GLP-1 combination therapy. (Doctoral Dissertation). University of Cambridge. Retrieved from https://www.repository.cam.ac.uk/handle/1810/296452

Chicago Manual of Style (16th Edition):

Roth, Emma Maria. “Central mechanisms underlying the synergistic anorectic effect of CCK and GLP-1 combination therapy.” 2020. Doctoral Dissertation, University of Cambridge. Accessed April 17, 2021. https://www.repository.cam.ac.uk/handle/1810/296452.

MLA Handbook (7th Edition):

Roth, Emma Maria. “Central mechanisms underlying the synergistic anorectic effect of CCK and GLP-1 combination therapy.” 2020. Web. 17 Apr 2021.

Vancouver:

Roth EM. Central mechanisms underlying the synergistic anorectic effect of CCK and GLP-1 combination therapy. [Internet] [Doctoral dissertation]. University of Cambridge; 2020. [cited 2021 Apr 17]. Available from: https://www.repository.cam.ac.uk/handle/1810/296452.

Council of Science Editors:

Roth EM. Central mechanisms underlying the synergistic anorectic effect of CCK and GLP-1 combination therapy. [Doctoral Dissertation]. University of Cambridge; 2020. Available from: https://www.repository.cam.ac.uk/handle/1810/296452


University of Cambridge

16. Roth, Emma Maria. Central mechanisms underlying the synergistic anorectic effect of CCK and GLP-1 combination therapy.

Degree: PhD, 2019, University of Cambridge

 Combination therapies that enhance the effects of separate peptides while limiting adverse effects constitute a promising strategy to improve the efficacy of pharmacologic-based treatments of… (more)

Subjects/Keywords: CCK; GLP-1; combination; satiety; neuroanatomy; synergy; energy metabolism; food intake; c-fos; immunohistochemistry; phosphorylated ribosome capture; pTRAP; cholecystokinin; glucagon-like peptide-1; obesity

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Roth, E. M. (2019). Central mechanisms underlying the synergistic anorectic effect of CCK and GLP-1 combination therapy. (Doctoral Dissertation). University of Cambridge. Retrieved from https://doi.org/10.17863/CAM.43501 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.787871

Chicago Manual of Style (16th Edition):

Roth, Emma Maria. “Central mechanisms underlying the synergistic anorectic effect of CCK and GLP-1 combination therapy.” 2019. Doctoral Dissertation, University of Cambridge. Accessed April 17, 2021. https://doi.org/10.17863/CAM.43501 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.787871.

MLA Handbook (7th Edition):

Roth, Emma Maria. “Central mechanisms underlying the synergistic anorectic effect of CCK and GLP-1 combination therapy.” 2019. Web. 17 Apr 2021.

Vancouver:

Roth EM. Central mechanisms underlying the synergistic anorectic effect of CCK and GLP-1 combination therapy. [Internet] [Doctoral dissertation]. University of Cambridge; 2019. [cited 2021 Apr 17]. Available from: https://doi.org/10.17863/CAM.43501 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.787871.

Council of Science Editors:

Roth EM. Central mechanisms underlying the synergistic anorectic effect of CCK and GLP-1 combination therapy. [Doctoral Dissertation]. University of Cambridge; 2019. Available from: https://doi.org/10.17863/CAM.43501 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.787871


Duke University

17. Amiram, Miriam. Glucagon-Like Peptide-1 Depots for the Treatment of Type-2 Diabetes .

Degree: 2012, Duke University

Peptide drugs are an exciting class of pharmaceuticals currently in development for the treatment of a variety of diseases; however, their main drawback is… (more)

Subjects/Keywords: Biomedical engineering; Drug Delivery; Elastin Like Polypeptides; Glucagon Like Peptide-1

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Amiram, M. (2012). Glucagon-Like Peptide-1 Depots for the Treatment of Type-2 Diabetes . (Thesis). Duke University. Retrieved from http://hdl.handle.net/10161/5499

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Amiram, Miriam. “Glucagon-Like Peptide-1 Depots for the Treatment of Type-2 Diabetes .” 2012. Thesis, Duke University. Accessed April 17, 2021. http://hdl.handle.net/10161/5499.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Amiram, Miriam. “Glucagon-Like Peptide-1 Depots for the Treatment of Type-2 Diabetes .” 2012. Web. 17 Apr 2021.

Vancouver:

Amiram M. Glucagon-Like Peptide-1 Depots for the Treatment of Type-2 Diabetes . [Internet] [Thesis]. Duke University; 2012. [cited 2021 Apr 17]. Available from: http://hdl.handle.net/10161/5499.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Amiram M. Glucagon-Like Peptide-1 Depots for the Treatment of Type-2 Diabetes . [Thesis]. Duke University; 2012. Available from: http://hdl.handle.net/10161/5499

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Illinois – Urbana-Champaign

18. Mangian, Heather. Butyrate-induced upregulation of intestinal glucose transport and signaling pathways represent a possible nutrient therapy for individuals with malabsorptive disorders.

Degree: PhD, 0191, 2014, University of Illinois – Urbana-Champaign

 Individuals with significant intestinal malabsorption face challenges digesting and absorbing sufficient nutrients. A number of intestinal diseases, including celiac disease, short bowel syndrome (SBS), necrotizing… (more)

Subjects/Keywords: butyrate; malabsorption; glucose absorption; proglucagon; glucose transporter-2 (GLUT2); sodium-dependent glucose cotransporter-1 (SGLT1); Nutrient transport; glucagon-like peptide-1 (GLP-1); glucagon-like peptide-2 (GLP-2); distal intestine; proximal intestine; short chain fatty acid (SCFA); Free Fatty Acid Receptor 2 (FFAR2); Free Fatty Acid Receptor 3 (FFAR3); fermentation; intestine

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Mangian, H. (2014). Butyrate-induced upregulation of intestinal glucose transport and signaling pathways represent a possible nutrient therapy for individuals with malabsorptive disorders. (Doctoral Dissertation). University of Illinois – Urbana-Champaign. Retrieved from http://hdl.handle.net/2142/49775

Chicago Manual of Style (16th Edition):

Mangian, Heather. “Butyrate-induced upregulation of intestinal glucose transport and signaling pathways represent a possible nutrient therapy for individuals with malabsorptive disorders.” 2014. Doctoral Dissertation, University of Illinois – Urbana-Champaign. Accessed April 17, 2021. http://hdl.handle.net/2142/49775.

MLA Handbook (7th Edition):

Mangian, Heather. “Butyrate-induced upregulation of intestinal glucose transport and signaling pathways represent a possible nutrient therapy for individuals with malabsorptive disorders.” 2014. Web. 17 Apr 2021.

Vancouver:

Mangian H. Butyrate-induced upregulation of intestinal glucose transport and signaling pathways represent a possible nutrient therapy for individuals with malabsorptive disorders. [Internet] [Doctoral dissertation]. University of Illinois – Urbana-Champaign; 2014. [cited 2021 Apr 17]. Available from: http://hdl.handle.net/2142/49775.

Council of Science Editors:

Mangian H. Butyrate-induced upregulation of intestinal glucose transport and signaling pathways represent a possible nutrient therapy for individuals with malabsorptive disorders. [Doctoral Dissertation]. University of Illinois – Urbana-Champaign; 2014. Available from: http://hdl.handle.net/2142/49775


University of Adelaide

19. Bellman, Susan Marie. The effectiveness of GLP-1 analogues compared to DPP-4 inhibitors for beta cell function and diabetes related complications among adults with type 2 diabetes: a systematic review and meta-analysis.

Degree: 2016, University of Adelaide

 Continued loss of beta cell function is responsible for progressive deterioration of plasma glucose control and complications characteristic of type 2 diabetes. Two classes of… (more)

Subjects/Keywords: type 2 diabetes; beta cell function; beta cell preservation; dipeptidyl peptidase-4 inhibitors; DPP-4 inhibitors; glucagon-like peptide analogues; GLP-1 analogues

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Bellman, S. M. (2016). The effectiveness of GLP-1 analogues compared to DPP-4 inhibitors for beta cell function and diabetes related complications among adults with type 2 diabetes: a systematic review and meta-analysis. (Thesis). University of Adelaide. Retrieved from http://hdl.handle.net/2440/99884

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Bellman, Susan Marie. “The effectiveness of GLP-1 analogues compared to DPP-4 inhibitors for beta cell function and diabetes related complications among adults with type 2 diabetes: a systematic review and meta-analysis.” 2016. Thesis, University of Adelaide. Accessed April 17, 2021. http://hdl.handle.net/2440/99884.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Bellman, Susan Marie. “The effectiveness of GLP-1 analogues compared to DPP-4 inhibitors for beta cell function and diabetes related complications among adults with type 2 diabetes: a systematic review and meta-analysis.” 2016. Web. 17 Apr 2021.

Vancouver:

Bellman SM. The effectiveness of GLP-1 analogues compared to DPP-4 inhibitors for beta cell function and diabetes related complications among adults with type 2 diabetes: a systematic review and meta-analysis. [Internet] [Thesis]. University of Adelaide; 2016. [cited 2021 Apr 17]. Available from: http://hdl.handle.net/2440/99884.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Bellman SM. The effectiveness of GLP-1 analogues compared to DPP-4 inhibitors for beta cell function and diabetes related complications among adults with type 2 diabetes: a systematic review and meta-analysis. [Thesis]. University of Adelaide; 2016. Available from: http://hdl.handle.net/2440/99884

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Western Ontario

20. Guizzetti, Leonard M. Novel Mechanisms In The Sorting Of Proglucagon To The Secretory Granules Of The Regulated Secretory Pathway.

Degree: 2014, University of Western Ontario

 The prohormone proglucagon encodes for multiple peptide hormones, including glucagon, glucagon-like peptide-1 (GLP-1), and GLP-2, produced through tissue-specific processing by prohormone convertase (PC) 1/3 and… (more)

Subjects/Keywords: proglucagon; glucagon; GLP-1; peptide hormone; protein trafficking; confocal microscopy; Molecular Biology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Guizzetti, L. M. (2014). Novel Mechanisms In The Sorting Of Proglucagon To The Secretory Granules Of The Regulated Secretory Pathway. (Thesis). University of Western Ontario. Retrieved from https://ir.lib.uwo.ca/etd/2536

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Guizzetti, Leonard M. “Novel Mechanisms In The Sorting Of Proglucagon To The Secretory Granules Of The Regulated Secretory Pathway.” 2014. Thesis, University of Western Ontario. Accessed April 17, 2021. https://ir.lib.uwo.ca/etd/2536.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Guizzetti, Leonard M. “Novel Mechanisms In The Sorting Of Proglucagon To The Secretory Granules Of The Regulated Secretory Pathway.” 2014. Web. 17 Apr 2021.

Vancouver:

Guizzetti LM. Novel Mechanisms In The Sorting Of Proglucagon To The Secretory Granules Of The Regulated Secretory Pathway. [Internet] [Thesis]. University of Western Ontario; 2014. [cited 2021 Apr 17]. Available from: https://ir.lib.uwo.ca/etd/2536.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Guizzetti LM. Novel Mechanisms In The Sorting Of Proglucagon To The Secretory Granules Of The Regulated Secretory Pathway. [Thesis]. University of Western Ontario; 2014. Available from: https://ir.lib.uwo.ca/etd/2536

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Toronto

21. Tahmasebi, Melika Zadeh. Ileal Fatty Acid Sensing Mechanisms Regulate Glucose Homeostasis In Vivo.

Degree: 2015, University of Toronto

Long-chain-fatty acids (LCFAs) are found in the diet, whereas short-chain fatty acids (SCFAs) are byproducts of fermentation in the distal intestine. It remains to be… (more)

Subjects/Keywords: Diabetes; glucagon-like peptide-1; glucose production; ileum; intestine; rats; 0719

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Tahmasebi, M. Z. (2015). Ileal Fatty Acid Sensing Mechanisms Regulate Glucose Homeostasis In Vivo. (Masters Thesis). University of Toronto. Retrieved from http://hdl.handle.net/1807/81088

Chicago Manual of Style (16th Edition):

Tahmasebi, Melika Zadeh. “Ileal Fatty Acid Sensing Mechanisms Regulate Glucose Homeostasis In Vivo.” 2015. Masters Thesis, University of Toronto. Accessed April 17, 2021. http://hdl.handle.net/1807/81088.

MLA Handbook (7th Edition):

Tahmasebi, Melika Zadeh. “Ileal Fatty Acid Sensing Mechanisms Regulate Glucose Homeostasis In Vivo.” 2015. Web. 17 Apr 2021.

Vancouver:

Tahmasebi MZ. Ileal Fatty Acid Sensing Mechanisms Regulate Glucose Homeostasis In Vivo. [Internet] [Masters thesis]. University of Toronto; 2015. [cited 2021 Apr 17]. Available from: http://hdl.handle.net/1807/81088.

Council of Science Editors:

Tahmasebi MZ. Ileal Fatty Acid Sensing Mechanisms Regulate Glucose Homeostasis In Vivo. [Masters Thesis]. University of Toronto; 2015. Available from: http://hdl.handle.net/1807/81088


University of Toronto

22. Tahmasebi, Melika Zadeh. Ileal Fatty Acid Sensing Mechanisms Regulate Glucose Homeostasis In Vivo.

Degree: 2015, University of Toronto

Long-chain-fatty acids (LCFAs) are found in the diet, whereas short-chain fatty acids (SCFAs) are byproducts of fermentation in the distal intestine. It remains to be… (more)

Subjects/Keywords: Diabetes; glucagon-like peptide-1; glucose production; ileum; intestine; rats; 0719

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Tahmasebi, M. Z. (2015). Ileal Fatty Acid Sensing Mechanisms Regulate Glucose Homeostasis In Vivo. (Masters Thesis). University of Toronto. Retrieved from http://hdl.handle.net/1807/81087

Chicago Manual of Style (16th Edition):

Tahmasebi, Melika Zadeh. “Ileal Fatty Acid Sensing Mechanisms Regulate Glucose Homeostasis In Vivo.” 2015. Masters Thesis, University of Toronto. Accessed April 17, 2021. http://hdl.handle.net/1807/81087.

MLA Handbook (7th Edition):

Tahmasebi, Melika Zadeh. “Ileal Fatty Acid Sensing Mechanisms Regulate Glucose Homeostasis In Vivo.” 2015. Web. 17 Apr 2021.

Vancouver:

Tahmasebi MZ. Ileal Fatty Acid Sensing Mechanisms Regulate Glucose Homeostasis In Vivo. [Internet] [Masters thesis]. University of Toronto; 2015. [cited 2021 Apr 17]. Available from: http://hdl.handle.net/1807/81087.

Council of Science Editors:

Tahmasebi MZ. Ileal Fatty Acid Sensing Mechanisms Regulate Glucose Homeostasis In Vivo. [Masters Thesis]. University of Toronto; 2015. Available from: http://hdl.handle.net/1807/81087


University of Toronto

23. Mundil, Dhanwantee. Cardiovascular Effects and Mechanisms of Action of Glucagon-like Peptide-1 Metabolite, GLP-1(28-36).

Degree: PhD, 2015, University of Toronto

The incretin hormone, glucagon-like peptide-1 (GLP-1), is a cardioprotective peptide. GLP-1(28-36) is a C-terminal nonapeptide derived from the cleavage of GLP-1 by the endopeptidase NEP… (more)

Subjects/Keywords: Cardiovascular; Glucagon-like peptide-1; Incretins; Ischemia; Myocardial Infarction; 0719

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Mundil, D. (2015). Cardiovascular Effects and Mechanisms of Action of Glucagon-like Peptide-1 Metabolite, GLP-1(28-36). (Doctoral Dissertation). University of Toronto. Retrieved from http://hdl.handle.net/1807/75686

Chicago Manual of Style (16th Edition):

Mundil, Dhanwantee. “Cardiovascular Effects and Mechanisms of Action of Glucagon-like Peptide-1 Metabolite, GLP-1(28-36).” 2015. Doctoral Dissertation, University of Toronto. Accessed April 17, 2021. http://hdl.handle.net/1807/75686.

MLA Handbook (7th Edition):

Mundil, Dhanwantee. “Cardiovascular Effects and Mechanisms of Action of Glucagon-like Peptide-1 Metabolite, GLP-1(28-36).” 2015. Web. 17 Apr 2021.

Vancouver:

Mundil D. Cardiovascular Effects and Mechanisms of Action of Glucagon-like Peptide-1 Metabolite, GLP-1(28-36). [Internet] [Doctoral dissertation]. University of Toronto; 2015. [cited 2021 Apr 17]. Available from: http://hdl.handle.net/1807/75686.

Council of Science Editors:

Mundil D. Cardiovascular Effects and Mechanisms of Action of Glucagon-like Peptide-1 Metabolite, GLP-1(28-36). [Doctoral Dissertation]. University of Toronto; 2015. Available from: http://hdl.handle.net/1807/75686


University of Southern California

24. Jokiaho, Anne. The integration of peripheral and central glucose sensing with the rate of fall in glycemia.

Degree: PhD, Integrative and Evolutionary Biology, 2012, University of Southern California

 Iatrogenic hypoglycemia is the limiting factor to glycemic control in type I diabetes and in the course of late stages of type II diabetes. Profound,… (more)

Subjects/Keywords: hypoglycemia; portal-mesenteric glucose sensors; catecholaminergic neurons; glucagon-like peptide 1

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Jokiaho, A. (2012). The integration of peripheral and central glucose sensing with the rate of fall in glycemia. (Doctoral Dissertation). University of Southern California. Retrieved from http://digitallibrary.usc.edu/cdm/compoundobject/collection/p15799coll3/id/111129/rec/6908

Chicago Manual of Style (16th Edition):

Jokiaho, Anne. “The integration of peripheral and central glucose sensing with the rate of fall in glycemia.” 2012. Doctoral Dissertation, University of Southern California. Accessed April 17, 2021. http://digitallibrary.usc.edu/cdm/compoundobject/collection/p15799coll3/id/111129/rec/6908.

MLA Handbook (7th Edition):

Jokiaho, Anne. “The integration of peripheral and central glucose sensing with the rate of fall in glycemia.” 2012. Web. 17 Apr 2021.

Vancouver:

Jokiaho A. The integration of peripheral and central glucose sensing with the rate of fall in glycemia. [Internet] [Doctoral dissertation]. University of Southern California; 2012. [cited 2021 Apr 17]. Available from: http://digitallibrary.usc.edu/cdm/compoundobject/collection/p15799coll3/id/111129/rec/6908.

Council of Science Editors:

Jokiaho A. The integration of peripheral and central glucose sensing with the rate of fall in glycemia. [Doctoral Dissertation]. University of Southern California; 2012. Available from: http://digitallibrary.usc.edu/cdm/compoundobject/collection/p15799coll3/id/111129/rec/6908


Swedish University of Agricultural Sciences

25. Manell, Elin. Refinement of porcine models in diabetes and transplantation research.

Degree: 2020, Swedish University of Agricultural Sciences

 Animal models are widely used in biomedical research aiming to prevent and improve treatments of diseases. The 3Rs (replace, reduce, refine) are considered when working… (more)

Subjects/Keywords: Pig; 3Rs; training; diabetes mellitus; streptozotocin; oral glucose tolerance test; insulin; glucagon-like peptide-1; glucagon-like peptide-1 receptor; fatty acid; triglyceride; amino acid; cystatin-C; renal transplantation

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Manell, E. (2020). Refinement of porcine models in diabetes and transplantation research. (Doctoral Dissertation). Swedish University of Agricultural Sciences. Retrieved from https://pub.epsilon.slu.se/18702/

Chicago Manual of Style (16th Edition):

Manell, Elin. “Refinement of porcine models in diabetes and transplantation research.” 2020. Doctoral Dissertation, Swedish University of Agricultural Sciences. Accessed April 17, 2021. https://pub.epsilon.slu.se/18702/.

MLA Handbook (7th Edition):

Manell, Elin. “Refinement of porcine models in diabetes and transplantation research.” 2020. Web. 17 Apr 2021.

Vancouver:

Manell E. Refinement of porcine models in diabetes and transplantation research. [Internet] [Doctoral dissertation]. Swedish University of Agricultural Sciences; 2020. [cited 2021 Apr 17]. Available from: https://pub.epsilon.slu.se/18702/.

Council of Science Editors:

Manell E. Refinement of porcine models in diabetes and transplantation research. [Doctoral Dissertation]. Swedish University of Agricultural Sciences; 2020. Available from: https://pub.epsilon.slu.se/18702/


University of Toronto

26. Hadjiyianni, Irene Ioanna. The Role of Glucagon-like Peptides in Experimental Type 1 Diabetes.

Degree: 2010, University of Toronto

Type 1 diabetes mellitus (T1D) is an autoimmune disorder that targets the insulin-producing β-cells. The gut may play a role in the pathogenesis of T1D,… (more)

Subjects/Keywords: diabetes; glucagon-like peptides; GLP-1R; GLP-2; GLP-1; NOD mouse

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Hadjiyianni, I. I. (2010). The Role of Glucagon-like Peptides in Experimental Type 1 Diabetes. (Doctoral Dissertation). University of Toronto. Retrieved from http://hdl.handle.net/1807/24763

Chicago Manual of Style (16th Edition):

Hadjiyianni, Irene Ioanna. “The Role of Glucagon-like Peptides in Experimental Type 1 Diabetes.” 2010. Doctoral Dissertation, University of Toronto. Accessed April 17, 2021. http://hdl.handle.net/1807/24763.

MLA Handbook (7th Edition):

Hadjiyianni, Irene Ioanna. “The Role of Glucagon-like Peptides in Experimental Type 1 Diabetes.” 2010. Web. 17 Apr 2021.

Vancouver:

Hadjiyianni II. The Role of Glucagon-like Peptides in Experimental Type 1 Diabetes. [Internet] [Doctoral dissertation]. University of Toronto; 2010. [cited 2021 Apr 17]. Available from: http://hdl.handle.net/1807/24763.

Council of Science Editors:

Hadjiyianni II. The Role of Glucagon-like Peptides in Experimental Type 1 Diabetes. [Doctoral Dissertation]. University of Toronto; 2010. Available from: http://hdl.handle.net/1807/24763

27. 福田, 修志. Glucagon-Like Peptide-1 Strengthens the Barrier Integrity in Primary Cultures of Rat Brain Endothelial Cells Under Basal and Hyperglycemia Conditions : グルカゴン様ペプチド-1は通常時と高血糖時の初代培養ラット毛細血管内皮細胞のバリア機能を強化する.

Degree: 博士(医学), 2016, Nagasaki University / 長崎大学

 The objective of the present study was to determine the effects of glucagon-like peptide-1 (GLP-1) on barrier functions and to assess the underlying mechanism using… (more)

Subjects/Keywords: Blood-brain barrier; Glucagon-like peptide 1; cAMP/PKA signaling; Tight junctions; Hyperglycemia

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

福田, . (2016). Glucagon-Like Peptide-1 Strengthens the Barrier Integrity in Primary Cultures of Rat Brain Endothelial Cells Under Basal and Hyperglycemia Conditions : グルカゴン様ペプチド-1は通常時と高血糖時の初代培養ラット毛細血管内皮細胞のバリア機能を強化する. (Thesis). Nagasaki University / 長崎大学. Retrieved from http://hdl.handle.net/10069/37602

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

福田, 修志. “Glucagon-Like Peptide-1 Strengthens the Barrier Integrity in Primary Cultures of Rat Brain Endothelial Cells Under Basal and Hyperglycemia Conditions : グルカゴン様ペプチド-1は通常時と高血糖時の初代培養ラット毛細血管内皮細胞のバリア機能を強化する.” 2016. Thesis, Nagasaki University / 長崎大学. Accessed April 17, 2021. http://hdl.handle.net/10069/37602.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

福田, 修志. “Glucagon-Like Peptide-1 Strengthens the Barrier Integrity in Primary Cultures of Rat Brain Endothelial Cells Under Basal and Hyperglycemia Conditions : グルカゴン様ペプチド-1は通常時と高血糖時の初代培養ラット毛細血管内皮細胞のバリア機能を強化する.” 2016. Web. 17 Apr 2021.

Vancouver:

福田 . Glucagon-Like Peptide-1 Strengthens the Barrier Integrity in Primary Cultures of Rat Brain Endothelial Cells Under Basal and Hyperglycemia Conditions : グルカゴン様ペプチド-1は通常時と高血糖時の初代培養ラット毛細血管内皮細胞のバリア機能を強化する. [Internet] [Thesis]. Nagasaki University / 長崎大学; 2016. [cited 2021 Apr 17]. Available from: http://hdl.handle.net/10069/37602.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

福田 . Glucagon-Like Peptide-1 Strengthens the Barrier Integrity in Primary Cultures of Rat Brain Endothelial Cells Under Basal and Hyperglycemia Conditions : グルカゴン様ペプチド-1は通常時と高血糖時の初代培養ラット毛細血管内皮細胞のバリア機能を強化する. [Thesis]. Nagasaki University / 長崎大学; 2016. Available from: http://hdl.handle.net/10069/37602

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Duke University

28. Luginbuhl, Kelli Michelle. Recombinantly Engineered Polypeptides for Drug Delivery .

Degree: 2017, Duke University

  Novel drug delivery methods aims to improve the therapeutic efficacy by enhancing the molecule’s pharmacokinetic profile as well as increasing its accumulation at the… (more)

Subjects/Keywords: Biomedical engineering; Materials Science; Controlled release; Drug delivery; Drug depot; Glucagon-like peptide-1

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Luginbuhl, K. M. (2017). Recombinantly Engineered Polypeptides for Drug Delivery . (Thesis). Duke University. Retrieved from http://hdl.handle.net/10161/16310

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Luginbuhl, Kelli Michelle. “Recombinantly Engineered Polypeptides for Drug Delivery .” 2017. Thesis, Duke University. Accessed April 17, 2021. http://hdl.handle.net/10161/16310.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Luginbuhl, Kelli Michelle. “Recombinantly Engineered Polypeptides for Drug Delivery .” 2017. Web. 17 Apr 2021.

Vancouver:

Luginbuhl KM. Recombinantly Engineered Polypeptides for Drug Delivery . [Internet] [Thesis]. Duke University; 2017. [cited 2021 Apr 17]. Available from: http://hdl.handle.net/10161/16310.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Luginbuhl KM. Recombinantly Engineered Polypeptides for Drug Delivery . [Thesis]. Duke University; 2017. Available from: http://hdl.handle.net/10161/16310

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Vanderbilt University

29. Bloodworth, Melissa Harintho. Regulation of Immune Responses during Airway Inflammation.

Degree: PhD, Microbiology and Immunology, 2017, Vanderbilt University

 Allergic asthma is refractory to corticosteroid treatment in up to 10% of patients and often leads to hospital admissions caused by respiratory viral and/ or… (more)

Subjects/Keywords: type 2 immunity (Th2); gamma-delta 17 (γδ17) cells; STAT6; Klebsiella pneumoniae; glucagon-like peptide 1 (GLP-1); respiratory syncytial virus (RSV); phenome-wide association study (PheWAS); regulatory T cells (Tregs); prostacyclin (PGI2)

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Bloodworth, M. H. (2017). Regulation of Immune Responses during Airway Inflammation. (Doctoral Dissertation). Vanderbilt University. Retrieved from http://hdl.handle.net/1803/11246

Chicago Manual of Style (16th Edition):

Bloodworth, Melissa Harintho. “Regulation of Immune Responses during Airway Inflammation.” 2017. Doctoral Dissertation, Vanderbilt University. Accessed April 17, 2021. http://hdl.handle.net/1803/11246.

MLA Handbook (7th Edition):

Bloodworth, Melissa Harintho. “Regulation of Immune Responses during Airway Inflammation.” 2017. Web. 17 Apr 2021.

Vancouver:

Bloodworth MH. Regulation of Immune Responses during Airway Inflammation. [Internet] [Doctoral dissertation]. Vanderbilt University; 2017. [cited 2021 Apr 17]. Available from: http://hdl.handle.net/1803/11246.

Council of Science Editors:

Bloodworth MH. Regulation of Immune Responses during Airway Inflammation. [Doctoral Dissertation]. Vanderbilt University; 2017. Available from: http://hdl.handle.net/1803/11246


University of North Florida

30. Fetter, Katie L. Efficacy of Bydureon in Adults with Type 2 Diabetes.

Degree: 2014, University of North Florida

 Type 2 diabetes is still rapidly on the rise today, affecting 10.5% of individuals in the United States between the ages 45 to 64 and… (more)

Subjects/Keywords: Thesis; University of North Florida; UNF; Dissertations; Academic  – UNF  – Master of Science in Nursing; Dissertations; Academic  – UNF  – Nursing; Bydureon; Type 2 Diabetes; GLP 1 receptor agonist; Glucagon-like peptide 1  – Effectiveness  – Testing; Non-insulin-dependent diabetes  – Treatment  – Testing; Family Practice Nursing; Medicine and Health Sciences; Nursing

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Fetter, K. L. (2014). Efficacy of Bydureon in Adults with Type 2 Diabetes. (Thesis). University of North Florida. Retrieved from https://digitalcommons.unf.edu/etd/490

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Fetter, Katie L. “Efficacy of Bydureon in Adults with Type 2 Diabetes.” 2014. Thesis, University of North Florida. Accessed April 17, 2021. https://digitalcommons.unf.edu/etd/490.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Fetter, Katie L. “Efficacy of Bydureon in Adults with Type 2 Diabetes.” 2014. Web. 17 Apr 2021.

Vancouver:

Fetter KL. Efficacy of Bydureon in Adults with Type 2 Diabetes. [Internet] [Thesis]. University of North Florida; 2014. [cited 2021 Apr 17]. Available from: https://digitalcommons.unf.edu/etd/490.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Fetter KL. Efficacy of Bydureon in Adults with Type 2 Diabetes. [Thesis]. University of North Florida; 2014. Available from: https://digitalcommons.unf.edu/etd/490

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

[1] [2] [3] [4] [5] … [779]

.